Linked-in Link Twitter Link

Biotangents Secures £326,000 in Equity Finance

Dec 21, 2017

Scottish based Biotangents Ltd are developing timely diagnostics to improve livestock welfare.  Recently, the Company closed an equity financing round of £326,000 that will be used to progress their pen-side infectious disease test. The investment came from Kelvin Capital members and was supported by Innova Partnerships.

Commenting, Innova’s founder, Prof Steve Howell, said “The team at Biotangents have made significant progress over the last year and this investment will allow them to speed up product development.”

Biotangents CEO, Alan Hale, added “We have some exceptional individuals and founders, in Andy and Lina. Together, we are focussed on bringing to market cost-effective solutions to support livestock disease management and look forward to an exciting year ahead.”

The Company is currently located at the Pentlands Science Park just outside Edinburgh.